The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 58%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (1 analysts) rates it strong buy, with a mean price target of $120.
Mercury General Corporation
MCY · the NYSE · USD · 4,380 employees
Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Mercury General Corporation holds its Markdown at $102.65. Consolidating, no directional conviction, held for 69 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 69 days |
| Price at the screen | $102.65 |
| Valuation | 6.07 trailing · 8.38 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.92 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: insurance
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: insurance | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 16.9% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAuto cover looks cheap until ethics step in
Picture a driver in California filing a claim after a fender bender. The payout still has to come from an insurer that collects premiums, manages risk and hopes weather or lawsuits do not wipe out the year. Mercury General does exactly that, posting 10% revenue growth, a 14% profit margin and 38% ROE while trading at 8.9 times forward earnings with a modest 13% gap to our assessed value.
We pass outright. The ethical screen flags the entire insurance sector on prohibited keywords, and that single rule overrides every other number on the page. One analyst target sits at the same $120 level we use, yet the opportunity rating stays at none because the screen is non-negotiable.
P&C underwriting remains hostage to catastrophe losses, inflation in repair costs and state regulators who can cap rates overnight. A low multiple on peak earnings has trapped value investors before. Analysis, not advice.
| Forward P/E | 8.4xcheap for a company growing this fast |
| Trailing P/E | 6.1xvery cheap relative to earnings |
| EPS, trailing | 16.92 |
| EPS, forward | 12.25 |
| Revenue growth | +13.8%steady growth |
| Profit margin | 14.8%thin but positive margins |
| Return on equity | 39.0%an exceptional return on shareholder capital |
| Dividend yield | 126.00% |
| Debt to equity | 0.34minimal debt: a conservative balance sheet |
| Current ratio | 0.95below 1: short-term bills exceed liquid assets |
| Beta | 0.92steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 74.29 - 113.06 |
| Employees | 4,380 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMCY trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 58%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (1 analysts) rates it strong buy, with a mean price target of $120.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 58%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (1 analysts) rates it strong buy, with a mean price target of $120.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $99.05 | +2.2% | · | $1,022 | +2.2% |
| 2 months | $92.21 | +9.8% | · | $1,098 | +9.8% |
| 3 months | $87.58 | +15.6% | $0.32 | $1,160 | +16.0% |
| 6 months | $90.82 | +11.5% | $0.32 | $1,118 | +11.8% |
| 1 year | $64.15 | +57.9% | $1.27 | $1,598 | +59.8% |
| 2 years | $51.79 | +95.5% | $2.54 | $2,004 | +100.4% |
| 3 years | $27.65 | +266.3% | $3.82 | $3,801 | +280.1% |
| 5 years | $51.53 | +96.5% | $7.94 | $2,119 | +111.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MCY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.